The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.
- Conditions
- Peritoneal MetastasisGastric Cancer
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06597526
- Locations
- 🇨🇳
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai, Shanghai, China
Ultrasound Assessment of Isolated Distal Deep Vein Thrombosis
- Conditions
- IddvtPulmonary Embolism (PE)
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 800
- Registration Number
- NCT06596941
- Locations
- 🇨🇳
Ruijin Hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, China
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Hepatobiliary Malignancy
- Conditions
- Hepatobiliary Malignancy
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06597539
- Locations
- 🇨🇳
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai, Shanghai, China
Model of Predicting Biochemical Recurrence After Radical Prostate Cancer Based on Pre-treatment PSMA PET / MR Image Features
- Conditions
- Prostate Cancer
- Interventions
- Other: Observe
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 203
- Registration Number
- NCT06604377
- Locations
- 🇨🇳
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai, China
Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
- Conditions
- Esophageal Squamous Cell Cancer
- Interventions
- Radiation: lymphocyte-sparing radiotherapyRadiation: conventional radiotherapy
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 212
- Registration Number
- NCT06596954
- Locations
- 🇨🇳
Ruijin hospital, Shanghai jiaotong university school of medicine, Shanghai, China
The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
- Conditions
- Advanced Colorectal Cancer
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06601075
- Locations
- 🇨🇳
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai, Shanghai, China
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06601010
- Locations
- 🇨🇳
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai, Shanghai, China
Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN
- Conditions
- Primary IgA Nephropathy
- Interventions
- First Posted Date
- 2024-09-10
- Last Posted Date
- 2024-09-10
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06589752
- Locations
- 🇨🇳
Ruijin hospital, Shanghai, China
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer
- First Posted Date
- 2024-09-06
- Last Posted Date
- 2024-09-06
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06587061
- Locations
- 🇨🇳
Ruijin Hospital Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai, China
Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer
- Conditions
- Breast Cancer Invasive
- Interventions
- Radiation: SLND(clinical low risk)Radiation: SLND(clinical high risk, genomic low risk)Radiation: SLND alone ,clinical high risk and genomic high risk groupRadiation: Sentinel Lymph Node Dissection(SLND) + axillary lymph node dissection(ALND)
- First Posted Date
- 2024-09-04
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 205
- Registration Number
- NCT06583655
- Locations
- 🇨🇳
Ruijin hospital, Shanghai jiaotong university school of medicine, Shanghai, China